Literature DB >> 10625846

Customized EMG needle insertion guide for the muscle afferent block of jaw-deviation and jaw-opening dystonias.

K Yoshida1, R Kaji, A Takagi, T Iizuka.   

Abstract

OBJECTIVE: Jaw-opening and jaw-deviation dystonias are characterized by mouth opening or lateral shift of the mandible due to involuntary contraction of the lateral pterygoid muscle, causing difficulties in speech or mastication. We introduce the method of muscle afferent block by using a removable device for inserting a hollow electromyographic needle. STUDY
DESIGN: A technique for fabricating a customized needle insertion guide into the lateral pterygoid muscle is described. Using the device, intramuscular injection of lidocaine and ethanol was performed in 3 patients with jaw-opening dystonia and 2 with jaw-deviation dystonia. Subjective improvement was assessed on a linear self-rating scale ranging from 0 (no improvement) to 100 points (complete cure).
RESULTS: The overall subjective improvement was 72% +/- 16.4% without major side effects.
CONCLUSIONS: The device is very useful for safe and accurate injection into the lateral pterygoid muscle. The muscle afferent block is effective for jaw-opening and jaw-deviation dystonias.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625846     DOI: 10.1016/s1079-2104(99)70006-5

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  5 in total

1.  [Muscle afferent block in the treatment of oromandibular dystonia. Difference in effect between masticatory and lingual muscles].

Authors:  K Yoshida
Journal:  Nervenarzt       Date:  2003-05-13       Impact factor: 1.214

2.  Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

Review 3.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

4.  Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

5.  Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2021-08-29       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.